4.2 Article

The potential of FDG-PET/CT for detecting prostate cancer in patients with an elevated serum PSA level

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer

Bashar Zelhof et al.

BJU INTERNATIONAL (2009)

Article Oncology

Exclusion of inflammation in the differential diagnosis of an elevated prostate-specific antigen (PSA)

Stacy Loeb et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Diffuse FDG uptake in acute prostatitis

Pan-Fu Kao et al.

CLINICAL NUCLEAR MEDICINE (2008)

Article Oncology

PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients

V. Serretta et al.

PROSTATE CANCER AND PROSTATIC DISEASES (2008)

Review Urology & Nephrology

Molecular positron emission tomography and PET/CT imaging in urological malignancies

Torn Powles et al.

EUROPEAN UROLOGY (2007)

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging prostate cancer: A multidisciplinary perspective

Hedvig Hricak et al.

RADIOLOGY (2007)

Article Radiology, Nuclear Medicine & Medical Imaging

Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer

J Kotzerke et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)

Article Medicine, General & Internal

Prostate-specificy-antigen testing for early diagnosis of prostate cancer.

MJ Barry

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Radiology, Nuclear Medicine & Medical Imaging

Experience with carbon-11 choline positron emission tomography in prostate carcinoma

J Kotzerke et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2000)